作为癌症药物点的生殖线突变是癌症药物的目标
Tin-Yun Tang1, Karen Colbert Maresso2, Joanne Ngeow3,4
1Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
由于成本效益和针对生殖基因突变的新疗法,所有癌症患者的普遍生殖基因检测现在是可行的. 这种方法扩大了获得有效癌症治疗的机会.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 遗传性癌症综合征与特定的致病变体有关.
- 细菌系变异越来越多地被认为是跨瘤类型的可操作目标.
- 药物开发领域的进步提供了新的治疗策略.
研究的目的:
- 审查目前作为癌症药物点的生殖基因突变的现状.
- 为了比较生殖线检测的现有临床诊断方法.
- 讨论有前途的抗瘤药物和普遍生殖系检测的未来.
主要方法:
- 关于生殖系突变,诊断和治疗的当前文献的综述.
- 对药物开发进展的分析在合成致死性,免疫疗法和疫苗方面取得了进展.
- 评估普遍生殖系检测的可行性和影响.
主要成果:
- 治疗方面的进步证明了生殖系变异的可操作性.
- 流行病学研究表明,各种瘤类型的生殖系变异.
- 针对生殖线改变的多种新型药物已获得监管部门的批准.
结论:
- 全球生殖基因检测正在变得可行,对个性化癌症医学至关重要.
- 具有成本效益的高吞吐量测试有助于更广泛地获得针对性的治疗方法.
- 生殖线改变代表了越来越多的治疗可行的目标组合.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
相关概念视频
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
